Page 571 - Williams Hematology ( PDFDrive )

546 Part VI: The Erythrocyte Chapter 36: Pure Red Cell Aplasia 547

39. Glader BE, Backer K: Elevated red cell adenosine deaminase activity: A marker of 72. Brown KE, Hibbs JR, Gallinella G, et al: Resistance to parvovirus B19 infection due to
disordered erythropoiesis in Diamond-Blackfan anaemia and other haematologic dis- lack of virus receptor (erythrocyte P antigen). N Engl J Med 330(17):1192, 1994.
eases. Br J Haematol 68(2):165, 1988. 73. Anderson MJ, Higgins PG, Davis LR, et al: Experimental parvoviral infection in
40. Freedman MH: Pure red cell aplasia in childhood and adolescence: Pathogenesis and humans. J Infect Dis 152(2):257, 1985.
approaches to diagnosis. Br J Haematol 85(2):246, 1993. 74. Saarinen UM, Chorba TL, Tattersall P, et al: Human parvovirus B19-induced epidemic
41. Vlachos A, Muir E: How I treat Diamond-Blackfan anemia. Blood 116(19):3715, 2010. acute red cell aplasia in patients with hereditary hemolytic anemia. Blood 67(5):1411,
42. Willig TN, Niemeyer CM, Leblanc T, et al: Identification of new prognosis factors from 1986.
the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia 75. Chorba T, Coccia P, Holman RC, et al: The role of parvovirus B19 in aplastic crisis and
patients. DBA group of Société d’Hématologie et d’Immunologie Pédiatrique (SHIP), erythema infectiosum (fifth disease). J Infect Dis 154(3):383, 1986.
Gesellshaft für Pädiatrische Onkologie und Hamatologie (GPOH), and the European 76. Smith-Whitley K, Zhao H, Hodinka RL, et al: Epidemiology of human parvovirus B19
Society for Pediatric Hematology and Immunology (ESPHI). Pediatr Res 46(5):553, in children with sickle cell disease. Blood 103(2):422, 2004.
1999. 77. Serjeant BE, Hambleton IR, Kerr S, et al: Haematological response to parvovirus B19
43. Vlachos A BS, Dahl N, et al: Diagnosing and treating Diamond Blackfan anaemia: infection in homozygous sickle-cell disease. Lancet 358(9295):1779, 2001.
Results of an international clinical consensus conference. Br J Haematol 142:849, 2008. 78. Skeppner G, Kreuger A, Elinder G: Transient erythroblastopenia of childhood: Pro-
44. Janov AJ, Leong T, Nathan DG, et al: Diamond-Blackfan anemia. Natural history and spective study of 10 patients with special reference to viral infections. J Pediatr Hematol
sequelae of treatment. Medicine (Baltimore) 75(2):77, 1996. Oncol 24(4):294, 2002.
45. Willig TN, Gazda H, Sieff CA: Diamond-Blackfan anemia. Curr Opin Hematol 7(2):85, 79. Beresford CH, Macfarlane SD: Temporal clustering of transient erythroblastopenia
2000. (cytopenia) of childhood. Aust Paediatr J 23(6):351, 1987.
46. Navenot JM, Muller JY, Blanchard D: Expression of blood group I antigen and fetal 80. Bhambhani K, Inoue S, Sarnaik SA: Seasonal clustering of transient erythroblastopenia
hemoglobin in paroxysmal nocturnal hemoglobinuria. Transfusion 37(3):291, 1997. of childhood. Am J Dis Child 142(2):175, 1988.
47. Vlachos A, Federman N, Reyes-Haley C, et al: Hematopoietic stem cell transplantation 81. Hays T, Lane PA Jr, Shafer F: Transient erythroblastopenia of childhood. A review of
for Diamond Blackfan anemia: A report from the Diamond Blackfan Anemia Registry. 26 cases and reassessment of indications for bone marrow aspiration. Am J Dis Child
Bone Marrow Transplant 27(4):381, 2001. 143(5):605, 1989.
48. Mugishima H, Ohga S, Ohara A, et al: Hematopoietic stem cell transplantation for 82. Prassouli A, Papadakis V, Tsakris A, et al: Classic transient erythroblastopenia of child-
Diamond-Blackfan anemia: A report from the Aplastic Anemia Committee of the hood with human parvovirus B19 genome detection in the blood and bone marrow. J
Japanese Society of Pediatric Hematology. Pediatr Transplant 11(6):601, 2007. Pediatr Hematol Oncol 27(6):333, 2005.
49. Fagioli F, Quarello P, Zecca M, et al: Haematopoietic stem cell transplantation for 83. Young NS, Mortimer PP, Moore JG, et al: Characterization of a virus that causes tran-
Diamond Blackfan anaemia: A report from the Italian Association of Paediatric Hae- sient aplastic crisis. J Clin Invest 73(1):224, 1984.
matology and Oncology Registry. Br J Haematol 165(5):673, 2014. 84. Rogers BB, Rogers ZR, Timmons CF: Polymerase chain reaction amplification of archi-
50. Wynn RF, Grainger JD, Carr TF, et al: Failure of allogeneic bone marrow transplan- val material for parvovirus B19 in children with transient erythroblastopenia of child-
tation to correct Diamond-Blackfan anaemia despite haemopoietic stem cell engraft- hood. Pediatr Pathol Lab Med 16(3):471, 1996.
ment. Bone Marrow Transplant 24(7):803, 1999. 85. Gussetis ES, Peristeri J, Kitra V, et al: Clinical value of bone marrow cultures in child-
51. Ball SE, Tchernia G, Wranne L, et al: Is there a role for interleukin-3 in Diamond- hood pure red cell aplasia. J Pediatr Hematol Oncol 20(2):120, 1998.
Blackfan anaemia? Results of a European multicentre study. Br J Haematol 91(2):313, 1995. 86. Koenig HM, Lightsey AL, Nelson DP, et al: Immune suppression of erythropoiesis in
52. Ozsoylu S: High-dose intravenous corticosteroid treatment for patients with transient erythroblastopenia of childhood. Blood 54(3):742, 1979.
Diamond-Blackfan syndrome resistant or refractory to conventional treatment. Am J 87. Dessypris EN, Krantz SB, Roloff JS, et al: Mode of action of the IgG inhibitor of erythro-
Pediatr Hematol Oncol 10(3):217, 1988. poiesis in transient erythroblastopenia of children. Blood 59(1):114, 1982.
53. Leonard EM, Raefsky E, Griffith P, et al: Cyclosporine therapy of aplastic anaemia, con- 88. Tamary H, Kaplinsky C, Shvartzmayer S, et al: Transient erythroblastopenia of child-
genital and acquired red cell aplasia. Br J Haematol 72(2):278, 1989. hood. Evidence for cell-mediated suppression of erythropoiesis. Am J Pediatr Hematol
54. Marmont AM: Congenital hypoplastic anaemia refractory to corticosteroids but Oncol 15(4):386, 1993.
responding to cyclophosphamide and antilymphocytic globulin. Report of a case hav- 89. Gustavsson P, Klar J, Matsson H, et al: Familial transient erythroblastopenia of child-
ing responded with a transitory wave of dyserythropoiesis. Acta Haematol 60(2):90, hood is associated with the chromosome 19q13.2 region but not caused by mutations in
1978. coding sequences of the ribosomal protein S19 (RPS19) gene. Br J Haematol 119(1):261,
55. Rutella S, Pierelli L, Bonanno G, et al: Role for granulocyte colony-stimulating factor in 2002.
the generation of human T regulatory type 1 cells. Blood 100(7):2562, 2002. 90. Thompson DF, Gales MA: Drug-induced pure red cell aplasia. Pharmacotherapy
56. Narla A, Payne EM, Abayasekara N, et al: L-Leucine improves the anaemia in models 16(6):1002, 1996.
of Diamond Blackfan anaemia and the 5q− syndrome in a TP53-independent way. Br J 91. Dessypris EN, Redline S, Harris JW, et al: Diphenylhydantoin-induced pure red cell
Haematol 167(4):524, 2014. aplasia. Blood 65(4):789, 1985.
57. Hamaguchi I, Ooka A, Brun A, et al: Gene transfer improves erythroid development in 92. Mariette X, Mitjavila MT, Moulinie JP, et al: Rifampicin-induced pure red cell aplasia.
ribosomal protein S19-deficient Diamond-Blackfan anemia. Blood 100(8):2724, 2002. Am J Med 87(4):459, 1989.
58. Flygare J, Olsson K, Richter J, et al: Gene therapy of Diamond Blackfan anemia CD34(+) 93. Smith JC, Megason GC, Iyer RV, et al: Clinical characteristics of children with hered-
cells leads to improved erythroid development and engraftment following transplanta- itary hemolytic anemias and aplastic crisis: A 7-year review. South Med J 87(7):702,
tion. Exp Hematol 36(11):1428, 2008. 1994.
59. Lyngar E: Samtidig optreden av anemisk kriser hos 3 barn i en familie med hymolytisk 94. Kynaston JA, West NC, Reid MM: A regional experience of red cell aplasia. Eur J Pediatr
ikterus. Nord Med 14:1246, 1942. 152(4):306, 1993.
60. Owren PA: Congenital hemolytic jaundice; the pathogenesis of the hemolytic crisis. 95. Farhi DC, Luebbers EL, Rosenthal NS: Bone marrow biopsy findings in childhood
Blood 3(3):231, 1948. anemia: Prevalence of transient erythroblastopenia of childhood. Arch Pathol Lab Med
61. Dameshek W, Bloom ML: The events in the hemolytic crisis of hereditary spherocyto- 122(7):638, 1998.
sis, with particular reference to the reticulocytopenia, pancytopenia and an abnormal 96. Skeppner G, Wranne L: Transient erythroblastopenia of childhood in Sweden: Inci-
splenic mechanism. Blood 3(12):1381, 1948. dence and findings at the time of diagnosis. Acta Paediatr 82(6-7):574, 1993.
62. Chernoff AI, Josephson AM: Acute erythroblastopenia in sickle-cell anemia and infec- 97. Cherrick I, Karayalcin G, Lanzkowsky P: Transient erythroblastopenia of childhood.
tious mononucleosis. AMA Am J Dis Child 82(3):310, 1951. Prospective study of fifty patients. Am J Pediatr Hematol Oncol 16(4):320, 1994.
63. Singer K, Motulsky AG, Wile SA: Aplastic crisis in sickle cell anemia; a study of its 98. Glader BE: Diagnosis and management of red cell aplasia in children. Hematol Oncol
mechanism and its relationship to other types of hemolytic crises. J Lab Clin Med Clin North Am 1(3):431, 1987.
35(5):721, 1950. 99. Michelson AD, Marshall PC: Transient neurological disorder associated with transient
64. Pattison JR, Jones SE, Hodgson J, et al: Parvovirus infections and hypoplastic crisis in erythroblastopenia of childhood. Am J Pediatr Hematol Oncol 9(2):161, 1987.
sickle-cell anaemia. Lancet 1(8221):664, 1981. 100. Young RS, Rannels DE, Hilmo A, et al: Severe anemia in childhood presenting as tran-
65. Young NS, Brown KE: Parvovirus B19. N Engl J Med 350(6):586, 2004. sient ischemic attacks. Stroke 14(4):622, 1983.
66. Serjeant GR, Serjeant BE, Thomas PW, et al: Human parvovirus infection in homozy- 101. Chan GC, Kanwar VS, Wilimas J: Transient erythroblastopenia of childhood associated
gous sickle cell disease. Lancet 341(8855):1237, 1993. with transient neurologic deficit: Report of a case and review of the literature. J Paediatr
67. Serjeant GR, Topley JM, Mason K, et al: Outbreak of aplastic crises in sickle cell Child Health 34(3):299, 1998.
anaemia associated with parvovirus-like agent. Lancet 2(8247):595, 1981. 102. Skeppner G, Forestier E, Henter JI, et al: Transient red cell aplasia in siblings: A com-
68. Wranne L: Transient erythroblastopenia in infancy and childhood. Scand J Haematol mon environmental or a common hereditary factor? Acta Paediatr 87(1):43, 1998.
7(2):76, 1970. 103. Leuschner S, Bodewaldt-Radzun S, Rister M: Increase of CALLA-positive stimulated
69. van den Akker M, Dror Y, Odame I: Transient erythroblastopenia of childhood is an lymphoid cells in transient erythroblastopenia of childhood. Eur J Pediatr 149(8):551,
underdiagnosed and self-limiting disease. Acta Paediatr 103(7):e288, 2014. 1990.
70. Young N, Harrison M, Moore J, et al: Direct demonstration of the human parvovirus in 104. Kaznelson P: Zur Enstehung der Blut Plattchen. Verh Dtsch Ges Inn Med 34:557,
erythroid progenitor cells infected in vitro. J Clin Invest 74(6):2024, 1984. 1922.
71. Brown KE, Anderson SM, Young NS: Erythrocyte P antigen: Cellular receptor for B19 105. Baker RI, Manoharan A, de Luca E, et al: Pure red cell aplasia of pregnancy: A distinct
parvovirus. Science 262(5130):114, 1993. clinical entity. Br J Haematol 85(3):619, 1993.

Kaushansky_chapter 36_p0539-0548.indd 546 9/17/15 6:15 PM